TODD S. YOUNG - 01 Mar 2024 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Executive Vice President and Chief Financial Officer
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Todd S. Young
Issuer symbol
ELAN
Transactions as of
01 Mar 2024
Net transactions value
-$224,420
Form type
4
Filing time
05 Mar 2024, 16:32:58 UTC
Previous filing
29 Feb 2024
Next filing
21 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +43,903 +41% $0.000000 152,176 01 Mar 2024 Direct F1
transaction ELAN Common Stock Tax liability $224,420 -14,000 -9.2% $16.03 138,176 01 Mar 2024 Direct F2
transaction ELAN Common Stock Gift $0 -37,999 -28% $0.000000 100,177 05 Mar 2024 Direct F3
transaction ELAN Common Stock Gift $0 +37,999 +33% $0.000000 152,308 05 Mar 2024 By Living Trust F3
transaction ELAN Common Stock Gift $0 -1,500 -0.98% $0.000000 150,808 05 Mar 2024 By Living Trust F4
transaction ELAN Common Stock Gift $0 +1,500 +75% $0.000000 3,500 05 Mar 2024 As UTMA custodian for daughter F4
transaction ELAN Common Stock Gift $0 -1,500 -0.99% $0.000000 149,308 05 Mar 2024 By Living Trust F5
transaction ELAN Common Stock Gift $0 +1,500 +75% $0.000000 3,500 05 Mar 2024 As UTMA custodian for son F5
holding ELAN Common Stock 6,562 01 Mar 2024 By IRA
holding ELAN Common Stock 2,000 01 Mar 2024 By J. G. Young IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Employee Stock Option(right to buy) Award $0 +95,749 $0.000000 95,749 01 Mar 2024 Common Stock 95,749 $16.03 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2024, one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.
F2 Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
F3 On March 5, 2024, the reporting person transferred 37,999 directly owned shares to a living trust, of which the insider and his spouse are trustees and beneficiaries.
F4 Reflects a transfer to the reporting person as custodian for daughter under Uniform Gift to Minors Act.
F5 Reflects a transfer to the reporting person as custodian for son under Uniform Gift to Minors Act.
F6 Grant of stock options vesting as follows: one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.

Remarks:

Executive Vice President and Chief Financial Officer